Accenture (ACN) director granted 5 RSUs, now holds 3,708 shares

Accenture plc director reports small anti-dilution RSU grant A director of Accenture plc (ACN) reported receiving 5 Class A ordinary shares on 11/14/2025 through a grant of restricted share units.

Rhea-AI Filing Summary

Accenture plc director reports small anti-dilution RSU grant

A director of Accenture plc (ACN) reported receiving 5 Class A ordinary shares on 11/14/2025 through a grant of restricted share units. The filing explains that these RSUs were granted under the anti-dilution provisions of previously granted RSU awards to reflect Accenture's payment of a cash dividend, so the director did not pay any purchase price, which is shown as $0 per share. Following this adjustment, the director beneficially owns 3,708 Class A ordinary shares directly.

Insider Trade Summary

Grant/Award: 5 shares

Grant/Award 1 txn

Insider RENDUCHINTALA VENKATA S M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A ordinary shares	5	$0.00	$0.00

Holdings After Transaction: Class A ordinary shares — 3,708 shares (Direct)

Footnotes (1)

1. F1. Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.

FAQ

What insider transaction did Accenture (ACN) report in this Form 4?

The Form 4 reports that an Accenture director received 5 Class A ordinary shares on 11/14/2025 through a grant of restricted share units.

Why were the 5 restricted share units granted to the Accenture (ACN) director?

The 5 restricted share units were granted under the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.

What is the reported price for the Accenture (ACN) shares received by the director?

The transaction reports a price of $0 per share for the 5 Class A ordinary shares received through the restricted share unit grant.

How many Accenture (ACN) shares does the director own after this transaction?

After the reported transaction, the director beneficially owns 3,708 Class A ordinary shares of Accenture plc, held directly.

Does this Accenture (ACN) Form 4 involve derivative securities like options or warrants?

The Form 4 includes a table for derivative securities but shows no derivative transactions reported in that section for this event.

What is the role of the reporting person in relation to Accenture (ACN)?

The reporting person is identified as a Director of Accenture plc and is filing the Form 4 as a single reporting person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/18/2025 - 04:21 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

RENDUCHINTALA VENKATA S M

(Last) (First) (Middle)

C/O ACCENTURE

500 W. MADISON STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Accenture plc [ ACN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A ordinary shares	11/14/2025		A		5(1)	A	$0	3,708	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.

Remarks:

	/s/ Danika Haueisen, Attorney-in-Fact for Venkata S. M. Renduchintala	11/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.